CVS vs UNH
CVS and UNH side by side — valuation & fundamentals (public data).
Key statistics
| Metric | CVSCVS HEALTH Corp | UNHUnitedHealth Group Incorporated |
|---|---|---|
| Market cap | $135.08B | $382.02B |
| P/E (TTM) | 46.4 | 31.7 |
| P/B | 1.74 | 11.57 |
| P/S | 0.3x | 0.9x |
| Dividend yield | 2.51% | 2.07% |
| Revenue | $407.90B(TTM) | $449.71B(TTM) |
| Revenue growth (YoY) | 7.8% | 11.8% |
| Net income | $2.93B(TTM) | $12.04B(TTM) |
| Earnings growth (YoY) | -61.7% | -16.3% |
| EPS, diluted | $2.28(TTM) | $13.28(TTM) |
| EBIT margin | 1.2% | 4.2% |
| ROE | 2.3% | 36.5% |
| ROIC | 2.9% | 19.9% |
| Piotroski F | 6/9 | — |
| 1y total return | +86.6% | +67.4% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: CVS frente a UNH
| Métrica | CVS | UNH |
|---|---|---|
| Valor final | $14.3K | $38.7K |
| Retorno total | +42.8% | +286.5% |
| CAGR | +3.5% | +14.0% |
| Volatilidad | 28.6% | 29.9% |
| Sharpe | 0.13 | 0.46 |
| Sortino | 0.18 | 0.63 |
| Caída máxima | -56.8% | -61.4% |
Basado en 2600 días de negociación comunes, 2016-03-28 → 2026-07-29 · tasa libre de riesgo 3.9% (bono corto del Tesoro actual, mantenido constante)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)